NexImmune, Inc. (NEXI)
OTCMKTS: NEXI · Delayed Price · USD
1.340
-0.050 (-3.60%)
Jul 26, 2024, 3:57 PM EDT - Market closed
NexImmune Market Cap
NexImmune has a market cap or net worth of $1.84 million as of July 26, 2024. Its market cap has decreased by -74.83% in one year.
Market Cap
1.84M
Enterprise Value
-2.64M
1-Year Change
-74.83%
Ranking
n/a
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on February 12, 2021, NexImmune's market cap has decreased from $365.85M to $1.84M, a decrease of -99.50%. That is a compound annual growth rate of -78.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2024 | 5.40M | 134.78% |
| Dec 29, 2023 | 2.30M | -63.49% |
| Dec 30, 2022 | 6.30M | -93.98% |
| Dec 31, 2021 | 104.70M | -71.38% |
| Feb 12, 2021 | 365.85M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 817.23B |
| Novo Nordisk | 593.43B |
| UnitedHealth Group | 515.19B |
| Johnson & Johnson | 376.12B |
| Merck & Co. | 318.93B |
| AbbVie | 311.16B |
| AstraZeneca | 247.14B |
| Thermo Fisher | 219.38B |